USA - NASDAQ:PDCO - US7033951036 - Common Stock
The current stock price of PDCO is 31.33 USD. In the past month the price increased by 0.42%. In the past year, price increased by 20.41%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 24.24 | 100.93B | ||
| COR | CENCORA INC | 21.69 | 65.15B | ||
| CAH | CARDINAL HEALTH INC | 19.88 | 38.92B | ||
| HSIC | HENRY SCHEIN INC | 13.64 | 7.71B | ||
| AHCO | ADAPTHEALTH CORP | 30.35 | 1.27B | ||
| AHG | AKSO HEALTH GROUP | N/A | 900.69M | ||
| OMI | OWENS & MINOR INC | 3.75 | 423.28M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 74.97M | ||
| ATPC | AGAPE ATP CORP | N/A | 63.01M | ||
| COSM | COSMOS HEALTH INC | N/A | 27.79M | ||
| VRAX | VIRAX BIOLABS GROUP LTD | N/A | 2.53M | ||
| POM | POMDOCTOR LTD - ADR | N/A | 556.67M |
Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. The company is headquartered in Saint Paul, Minnesota and currently employs 7,600 full-time employees. The Company’s segments include Dental, Animal Health and Corporate. Its Dental segment provides consumable products (including infection control, restorative materials, and instruments); basic and advanced technology and dental equipment, and practice optimization solutions, including practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education. Its Animal Health segment is a full-line distributor in North America and the United Kingdom of animal health products, services and technologies to both the production-animal and companion-pet markets. The company offers a private label portfolio of products to veterinarians, producers, and retailers through its Aspen, First Companion and Patterson Veterinary brands.
PATTERSON COS INC
1031 Mendota Heights Rd
Saint Paul MINNESOTA 55120 US
CEO: Mark S. Walchirk
Employees: 7600
Phone: 16516861600
Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. The company is headquartered in Saint Paul, Minnesota and currently employs 7,600 full-time employees. The Company’s segments include Dental, Animal Health and Corporate. Its Dental segment provides consumable products (including infection control, restorative materials, and instruments); basic and advanced technology and dental equipment, and practice optimization solutions, including practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education. Its Animal Health segment is a full-line distributor in North America and the United Kingdom of animal health products, services and technologies to both the production-animal and companion-pet markets. The company offers a private label portfolio of products to veterinarians, producers, and retailers through its Aspen, First Companion and Patterson Veterinary brands.
The current stock price of PDCO is 31.33 USD. The price increased by 0.03% in the last trading session.
PATTERSON COS INC (PDCO) has a dividend yield of 3.32%. The yearly dividend amount is currently 1.06.
PDCO has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
19 analysts have analysed PDCO and the average price target is 30.88 USD. This implies a price decrease of -1.43% is expected in the next year compared to the current price of 31.33.
The next ex-dividend date for PATTERSON COS INC (PDCO) is October 18, 2024.
PATTERSON COS INC (PDCO) currently has 7600 employees.
ChartMill assigns a technical rating of 8 / 10 to PDCO. When comparing the yearly performance of all stocks, PDCO is one of the better performing stocks in the market, outperforming 85.96% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to PDCO. PDCO has an average financial health and profitability rating.
Over the last trailing twelve months PDCO reported a non-GAAP Earnings per Share(EPS) of 1.96. The EPS decreased by -15.88% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.13% | ||
| ROA | 4.9% | ||
| ROE | 14.02% | ||
| Debt/Equity | 0.63 |
19 analysts have analysed PDCO and the average price target is 30.88 USD. This implies a price decrease of -1.43% is expected in the next year compared to the current price of 31.33.
For the next year, analysts expect an EPS growth of -5.78% and a revenue growth 0.42% for PDCO